Insulin Pumps and Accessories Global Market - Forecast to 2026
Insulin pumps and accessories are class of medical devices used for administering insulin in a controlled, precise and automated manner. These devices used in the treatment of diabetes mellitus know as continuous subcutaneous insulin infusion, these insulin systems help in avoiding medical errors which would lead to serious life-threatening circumstances or even sometimes to death of a patient.
Insulin pumps & accessories market is segmented on the basis of products, applications, end-users and geography. The insulin pumps & accessories products market is segmented into insulin pumps, consumables, among them insulin pumps held the largest share of the market with XX% in 2019 and are expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Insulin pumps are further sub-segmented into tethered insulin pumps and patch insulin pumps. The tethered insulin pump accounted for the largest share of XX% in 2019 and is expected to grow at a mid single digit CAGR of XX% from 2019 to 2026. Applications market is segmented into type 1 diabetes and type 2 diabetes, among them, the type 1 diabetes segment held the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026. End-users market is classified into hospitals, ambulatory surgical centers, homecare and others. Among them, home healthcare commanded the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026.
Geographically, North America is the largest market, with a share of XX% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a high single digit CAGR of XX% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the insulin pumps & accessories market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The insulin pumps & accessories market is expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Increase in the prevalence of diabetes, technological advancements, adoption of insulin pumps over traditional methods and advantages of insulin pumps over the injections and pens are the factors driving the market growth. The increasing trend for wireless insulin pumps, emergence of smart pumps and market expansion in emerging nations and product approvals are expected to offer potential opportunities.
However, various factors like, high cost, patient safety risks and medication errors associated with insulin pumps, lack of cyber-security in wireless insulin pumps limit the growth of insulin pumps & accessories global market.
The insulin pumps & accessories global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in insulin pumps & accessories market include F. Hoffmann-La Roche AG (Switzerland), Insulet Corporation (U.S.), Medtronic PLC (Ireland), Tandem Diabetes Care Inc. (U.S.), Valeritas Holdings Inc. (U.S.) and Ypsomed Holdings AG (Switzerland).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
Insulin pumps & accessories market is segmented on the basis of products, applications, end-users and geography. The insulin pumps & accessories products market is segmented into insulin pumps, consumables, among them insulin pumps held the largest share of the market with XX% in 2019 and are expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Insulin pumps are further sub-segmented into tethered insulin pumps and patch insulin pumps. The tethered insulin pump accounted for the largest share of XX% in 2019 and is expected to grow at a mid single digit CAGR of XX% from 2019 to 2026. Applications market is segmented into type 1 diabetes and type 2 diabetes, among them, the type 1 diabetes segment held the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026. End-users market is classified into hospitals, ambulatory surgical centers, homecare and others. Among them, home healthcare commanded the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026.
Geographically, North America is the largest market, with a share of XX% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a high single digit CAGR of XX% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the insulin pumps & accessories market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The insulin pumps & accessories market is expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Increase in the prevalence of diabetes, technological advancements, adoption of insulin pumps over traditional methods and advantages of insulin pumps over the injections and pens are the factors driving the market growth. The increasing trend for wireless insulin pumps, emergence of smart pumps and market expansion in emerging nations and product approvals are expected to offer potential opportunities.
However, various factors like, high cost, patient safety risks and medication errors associated with insulin pumps, lack of cyber-security in wireless insulin pumps limit the growth of insulin pumps & accessories global market.
The insulin pumps & accessories global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in insulin pumps & accessories market include F. Hoffmann-La Roche AG (Switzerland), Insulet Corporation (U.S.), Medtronic PLC (Ireland), Tandem Diabetes Care Inc. (U.S.), Valeritas Holdings Inc. (U.S.) and Ypsomed Holdings AG (Switzerland).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Rest of North America
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of APAC
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 The global rise in the prevalence and incidence of diabetes
3.3.1.2 Increase in the use of insulin pumps in-home care settings and disadvantages of conventional methods over insulin pumps.
3.3.1.3 Increasing distribution agreements, partnerships and collaboration activities
3.3.1.4 Increase in product approvals
3.3.2 RESTRAINS AND THREATS
3.3.2.1 High cost of the continuous subcutaneous insulin infusion therapy(csii)
3.3.2.2 Inadequate reimbursement
3.3.2.3 Increased product recalls
3.3.2.4 Privacy concern and safety issues associated with insulin pumps
3.3.2.5 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO:9001: 2015 quality management system
3.4.1.2 ISO:13485 medical devices
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 INDIA
3.4.6 CHINA
3.4.7 JAPAN
3.5 CLINICAL TRIALS
3.6 PRODUCT RECALLS
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 RIVALRY AMONG EXISTING COMPETITORS
3.7.4 BARGAINING POWER OF SUPPLIERS
3.7.5 BARGAINING POWER OF BUYERS
3.8 SUPPLY CHAIN ANALYSIS
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.9.1 INSULIN PUMPS AND ACCESSORIES MARKET SHARE ANALYSIS
3.10 NUMBER OF UNITS SOLD
3.11 MARKET PENETRATION
4 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INSULIN PUMPS
4.2.1 TETHERED INSULIN PUMP
4.2.2 PATCH INSULIN PUMP
4.3 CONSUMABLES
5 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 TYPE 1 DIABETES
5.3 TYPE 2 DIABETES
6 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY END-USER
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS
7 INSULIN PUMPS AND ACCESSORIES MARKET BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 U.K.
7.3.4 REST OF EUROPE
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVAL
8.3 AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS
8.4 NEW PRODUCT LAUNCH
8.5 OTHERS
9 MAJOR COMPANIES
9.1 DEBIOTECH S.A.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 DIABELOOP S.A.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 F. HOFFMANN-LA ROCHE AG.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 INSULET CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 MEDTRONIC PLC
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MICROPORT SCIENTIFIC CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 SOOIL DEVELOPMENT CO. LTD.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 TANDEM DIABETES CARE INC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 VALERITAS HOLDINGS INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 YPSOMED HOLDING AG.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 The global rise in the prevalence and incidence of diabetes
3.3.1.2 Increase in the use of insulin pumps in-home care settings and disadvantages of conventional methods over insulin pumps.
3.3.1.3 Increasing distribution agreements, partnerships and collaboration activities
3.3.1.4 Increase in product approvals
3.3.2 RESTRAINS AND THREATS
3.3.2.1 High cost of the continuous subcutaneous insulin infusion therapy(csii)
3.3.2.2 Inadequate reimbursement
3.3.2.3 Increased product recalls
3.3.2.4 Privacy concern and safety issues associated with insulin pumps
3.3.2.5 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO:9001: 2015 quality management system
3.4.1.2 ISO:13485 medical devices
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 INDIA
3.4.6 CHINA
3.4.7 JAPAN
3.5 CLINICAL TRIALS
3.6 PRODUCT RECALLS
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 RIVALRY AMONG EXISTING COMPETITORS
3.7.4 BARGAINING POWER OF SUPPLIERS
3.7.5 BARGAINING POWER OF BUYERS
3.8 SUPPLY CHAIN ANALYSIS
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.9.1 INSULIN PUMPS AND ACCESSORIES MARKET SHARE ANALYSIS
3.10 NUMBER OF UNITS SOLD
3.11 MARKET PENETRATION
4 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INSULIN PUMPS
4.2.1 TETHERED INSULIN PUMP
4.2.2 PATCH INSULIN PUMP
4.3 CONSUMABLES
5 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 TYPE 1 DIABETES
5.3 TYPE 2 DIABETES
6 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY END-USER
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS
7 INSULIN PUMPS AND ACCESSORIES MARKET BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 U.K.
7.3.4 REST OF EUROPE
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVAL
8.3 AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS
8.4 NEW PRODUCT LAUNCH
8.5 OTHERS
9 MAJOR COMPANIES
9.1 DEBIOTECH S.A.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 DIABELOOP S.A.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 F. HOFFMANN-LA ROCHE AG.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 INSULET CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 MEDTRONIC PLC
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MICROPORT SCIENTIFIC CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 SOOIL DEVELOPMENT CO. LTD.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 TANDEM DIABETES CARE INC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 VALERITAS HOLDINGS INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 YPSOMED HOLDING AG.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 INSULIN PUMPS GLOBAL UNITS SOLD, BY REGION, (2018-2026) (NOS.)
TABLE 3 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 4 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 5 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCT (2018-2026) ($MN)
TABLE 6 TETHERED INSULIN PUMP GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 PATCH INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 9 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 10 TYPE 1 DIABETES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 11 TYPE 2 DIABETES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 12 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 13 HOSPITAL GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 14 AMBULATORY GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 15 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 16 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 17 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 18 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 19 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 20 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 21 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 22 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 23 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 24 EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 25 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 26 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 27 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 28 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 29 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCTS(2018-2026) ($MN)
TABLE 30 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 31 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 32 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 33 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 34 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 35 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 36 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 37 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 38 APPROVALS (2018-2019)
TABLE 39 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2018-2019)
TABLE 40 NEW PRODUCT LAUNCH (2018-2019)
TABLE 41 OTHERS (2018-2019)
TABLE 42 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 43 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE BY SEGMENTS, (2017-2019) (Q3) ($MN)
TABLE 44 F. HOFFMANN-LA ROCHE AG: DIAGNOSTICS REVENUE, BY TYPES, (2017-2019) (Q3) ($MN)
TABLE 45 F. HOFFMANN-LA ROCHE AG: DIABETES CARE REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
TABLE 46 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
TABLE 47 INSULET CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 48 INSULET CORPORATION: TOTAL REVENUE, BY SEGMENTS,(2017-2019) (Q3) ($MN)
TABLE 49 INSULET CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 50 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
TABLE 51 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2016-2018) ($MN)
TABLE 52 MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2016-2018) ($MN)
TABLE 53 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
TABLE 54 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q2)($MN)
TABLE 55 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) (Q2) ($MN)
TABLE 56 TANDEM DIABETES CARE, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 57 TANDEM DIABETES CARE, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q3) ($MN)
TABLE 58 TANDEM DIABETES CARE, INC.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 59 VALERITAS HOLDINS INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
TABLE 60 YPSOMED HOLDING AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
TABLE 61 YPSOMED HOLDING AG: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q2) ($MN)
TABLE 62 YPSOMED HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q2) ($MN)
TABLE 1 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 INSULIN PUMPS GLOBAL UNITS SOLD, BY REGION, (2018-2026) (NOS.)
TABLE 3 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 4 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 5 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCT (2018-2026) ($MN)
TABLE 6 TETHERED INSULIN PUMP GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 PATCH INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 9 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 10 TYPE 1 DIABETES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 11 TYPE 2 DIABETES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 12 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 13 HOSPITAL GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 14 AMBULATORY GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 15 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 16 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 17 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 18 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 19 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 20 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 21 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 22 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 23 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 24 EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 25 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 26 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 27 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 28 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 29 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCTS(2018-2026) ($MN)
TABLE 30 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 31 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 32 APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 33 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 34 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 35 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 36 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 37 ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 38 APPROVALS (2018-2019)
TABLE 39 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2018-2019)
TABLE 40 NEW PRODUCT LAUNCH (2018-2019)
TABLE 41 OTHERS (2018-2019)
TABLE 42 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 43 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE BY SEGMENTS, (2017-2019) (Q3) ($MN)
TABLE 44 F. HOFFMANN-LA ROCHE AG: DIAGNOSTICS REVENUE, BY TYPES, (2017-2019) (Q3) ($MN)
TABLE 45 F. HOFFMANN-LA ROCHE AG: DIABETES CARE REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
TABLE 46 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
TABLE 47 INSULET CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 48 INSULET CORPORATION: TOTAL REVENUE, BY SEGMENTS,(2017-2019) (Q3) ($MN)
TABLE 49 INSULET CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 50 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
TABLE 51 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2016-2018) ($MN)
TABLE 52 MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2016-2018) ($MN)
TABLE 53 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
TABLE 54 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q2)($MN)
TABLE 55 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) (Q2) ($MN)
TABLE 56 TANDEM DIABETES CARE, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 57 TANDEM DIABETES CARE, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q3) ($MN)
TABLE 58 TANDEM DIABETES CARE, INC.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 59 VALERITAS HOLDINS INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
TABLE 60 YPSOMED HOLDING AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
TABLE 61 YPSOMED HOLDING AG: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q2) ($MN)
TABLE 62 YPSOMED HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q2) ($MN)
LIST OF FIGURES
FIGURE 1 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET
FIGURE 3 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 INSULIN PUMPS UNITS SOLD, BY REGION AND COUNTRYWISE, (2019) (NOS.)
FIGURE 12 INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 13 INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 14 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 15 INSULIN PUMP GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 16 PATCH INSULIN PUMP GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 17 CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 18 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 19 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 20 HOME HEALTHCARE GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 21 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 22 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY REGIONAL MARKET REVENUE (2019) (%) ($MN)
FIGURE 23 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 24 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 25 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 26 NORTH AMERICA INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 27 NORTH AMERICA INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 28 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 29 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 30 U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 31 U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 32 U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 33 REST OF NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 34 REST NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 35 REST OF NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 36 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 37 EUROPE INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 38 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 39 EUROPE INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 40 EUROPE INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 41 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 42 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 43 GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 44 GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 45 GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 46 FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 47 FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 48 FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 49 U.K. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 50 U.K. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 51 U.K INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 52 REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 53 REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 54 REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 55 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 56 APAC INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 57 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 58 APAC INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 59 APAC INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 60 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 61 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 62 JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 63 JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 64 JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 65 CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 66 CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 67 CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 68 INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 69 INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 70 INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 71 REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 72 REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 73 REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 74 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 75 ROW INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 76 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 77 ROW INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 78 ROW INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 79 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 80 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 81 BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 82 BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 83 BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 84 REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 85 REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 86 REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 87 MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 88 MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 89 MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 90 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 91 SWOT: DEBIOTECH S.A.
FIGURE 92 SWOT: DIABELOOP S.A.
FIGURE 93 SWOT: F. HOFFMANN-LA ROCHE AG
FIGURE 94 SWOT: INSULET CORPORATION
FIGURE 95 SWOT: MEDTRONIC PLC
FIGURE 96 SWOT: MICROPORT SCIENTIFIC CORPORATION
FIGURE 97 SWOT: SOOIL DEVELOPMENT CO. LTD.
FIGURE 98 SWOT: TANDEM DIABETES CARE INC.
FIGURE 99 SWOT: VALERITAS HOLDINGS, INC.
FIGURE 100 SWOT: YPSOMED HOLDING AG
FIGURE 1 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET
FIGURE 3 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 INSULIN PUMPS UNITS SOLD, BY REGION AND COUNTRYWISE, (2019) (NOS.)
FIGURE 12 INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 13 INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 14 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 15 INSULIN PUMP GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 16 PATCH INSULIN PUMP GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 17 CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 18 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 19 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 20 HOME HEALTHCARE GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 21 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 22 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY REGIONAL MARKET REVENUE (2019) (%) ($MN)
FIGURE 23 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 24 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 25 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 26 NORTH AMERICA INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 27 NORTH AMERICA INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 28 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 29 NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 30 U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 31 U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 32 U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 33 REST OF NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 34 REST NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 35 REST OF NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 36 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 37 EUROPE INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 38 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 39 EUROPE INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 40 EUROPE INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 41 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 42 EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 43 GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 44 GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 45 GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 46 FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 47 FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 48 FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 49 U.K. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 50 U.K. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 51 U.K INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 52 REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 53 REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 54 REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 55 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 56 APAC INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 57 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 58 APAC INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 59 APAC INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 60 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 61 APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 62 JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 63 JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 64 JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 65 CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 66 CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 67 CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 68 INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 69 INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 70 INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 71 REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 72 REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 73 REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 74 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 75 ROW INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
FIGURE 76 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 77 ROW INSULIN PUMPS MARKET PENETRATION, (2019)
FIGURE 78 ROW INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
FIGURE 79 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 80 ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 81 BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 82 BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 83 BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 84 REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 85 REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 86 REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 87 MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
FIGURE 88 MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 89 MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 90 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 91 SWOT: DEBIOTECH S.A.
FIGURE 92 SWOT: DIABELOOP S.A.
FIGURE 93 SWOT: F. HOFFMANN-LA ROCHE AG
FIGURE 94 SWOT: INSULET CORPORATION
FIGURE 95 SWOT: MEDTRONIC PLC
FIGURE 96 SWOT: MICROPORT SCIENTIFIC CORPORATION
FIGURE 97 SWOT: SOOIL DEVELOPMENT CO. LTD.
FIGURE 98 SWOT: TANDEM DIABETES CARE INC.
FIGURE 99 SWOT: VALERITAS HOLDINGS, INC.
FIGURE 100 SWOT: YPSOMED HOLDING AG
